On Wednesday, Dec. 11, Marcela Mazo Canola, MD, breast oncologist at Mays Cancer Center and assistant professor in the Division of Hematology and Oncology at UT Health San Antonio, will present a ...
Dec. 12, 2024 — Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, into molecular ...
Dec. 13, 2024 — A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study ...
A regimen using the PD-L1 inhibitor atezolizumab in the neoadjuvant and adjuvant settings did not improve outcomes in patients with triple-negative breast cancer. The phase 3 EMBER-3 trial showed ...
Breast cancer outcomes are significantly impacted by race and immune responses, particularly among Black patients with triple-negative subtypes, emphasizing the need to understand these ...
Australian-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has revolutionized treatment for patients, whereby the body's own immune system is ...
SAN ANTONIO, Dec. 9, 2024 – Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in partnership with the American Association for Cancer ...
Lost in a daydream? The Cancer moon teams up with Neptune to send your mind on a fantastical adventure. Escape into the visions that bubble up. The ability to see the future may not be so far-fetched.
The research was discussed Thursday at the San Antonio Breast Cancer Symposium. Every year, about 50,000 women in the U.S. are diagnosed with ductal carcinoma in situ, or DCIS, where the cells ...
Add to that the cost of treating cancer, and it’s clear how difficult this season can be for some families But the San Diego community can make a difference and generate hope for those who are ...